Hypothesis testing: One-tailed and two-tailed tests

10,215views

Hypothesis testing: One-tailed and two-tailed tests

BMB2

BMB2

Seizures: Pathology review
Seizures: Clinical
Febrile seizure
Seizures and epilepsy
Early infantile epileptic encephalopathy (NORD)
Nonbenzodiazepine anticonvulsants
Migraine medications
Migraine
Neuron action potential
Resting membrane potential
Concussion and traumatic brain injury
Sleep
Sleep disorders: Clinical
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Essential tremor
Malingering, factitious disorders and somatoform disorders: Pathology review
Somatic symptom disorders: Clinical
Somatic symptom disorder
Dissociative disorders
Dissociative disorders: Clinical
Amnesia, dissociative disorders and delirium: Pathology review
Narcolepsy (NORD)
Psychomotor stimulants
Trigeminal neuralgia
Muscle weakness: Clinical
Myalgias and myositis: Pathology review
Fibromyalgia
Diabetic nephropathy
Tricyclic antidepressants
Atypical antidepressants
Medications for neurodegenerative diseases
Toxidromes: Clinical
Body focused repetitive disorders
Headaches: Clinical
Demyelinating disorders: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Erb-Duchenne palsy
Klumpke paralysis
Lead poisoning
Hemolytic-uremic syndrome
Vitamin B12 deficiency
Monoclonal gammopathy of undetermined significance
Charcot-Marie-Tooth disease
Inflammatory myopathies: Clinical
Guillain-Barre syndrome
Amyotrophic lateral sclerosis
Spinal muscular atrophy
Muscular dystrophy
Spinal cord reflexes
Myotonic dystrophy
Memory palaces
Herpes simplex virus
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle contraction
Development of the muscular system
Development of the axial skeleton
Patellar tendon rupture
Achilles tendon rupture
Lower back pain: Clinical
Carpal tunnel syndrome
Radial head subluxation (Nursemaid elbow)
Bell palsy
Headaches: Pathology review
Cluster headache
Tension headache
Epidural hematoma
Traumatic brain injury: Clinical
Intracerebral hemorrhage
Subarachnoid hemorrhage
Subdural hematoma
Traumatic brain injury: Pathology review
Idiopathic intracranial hypertension
Vasculitis
Vasculitis: Clinical
Dementia with Lewy bodies
Spinocerebellar ataxia (NORD)
Amyloidosis
Vascular dementia
Dementia and delirium: Clinical
Frontotemporal dementia
Dementia: Pathology review
Hypokinetic movement disorders: Clinical
Alzheimer disease
Movement disorders: Pathology review
Delirium
Parkinson disease
Hyperkinetic movement disorders: Clinical
Back pain: Pathology review
Stroke: Clinical
Compartment syndrome
Macrocytic anemia: Pathology review
Hypokalemia: Clinical
Hyperkalemia: Clinical
Hypothesis testing: One-tailed and two-tailed tests
Paired t-test
One-way ANOVA
Two-way ANOVA
Type I and type II errors
Two-sample t-test
Correlation
Repeated measures ANOVA
Meningitis, encephalitis and brain abscesses: Clinical
Neonatal meningitis
Central nervous system infections: Pathology review
Neisseria meningitidis
Streptococcus pneumoniae
Listeria monocytogenes
Brain abscess
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Encephalitis
Eastern and Western equine encephalitis virus
West Nile virus
Zika virus
Rabies virus
Poliovirus
JC virus (Progressive multifocal leukoencephalopathy)
Knowledge Shot: What is acute flaccid myelitis, the polio-like paralyzing disease
Meningitis
Cryptococcus neoformans
Aspergillus fumigatus
Candida
Mucormycosis
Coccidioidomycosis and paracoccidioidomycosis
Blastomycosis
Histoplasmosis
Chi-squared test
Naegleria fowleri (Primary amebic meningoencephalitis)
Angiostrongylus (Eosinophilic meningitis)
Varicella zoster virus
Mycobacterium tuberculosis (Tuberculosis)
Normal pressure hydrocephalus
Prions (Spongiform encephalopathy)
Measles virus
Central nervous system infections: Pathology review
Meningitis, encephalitis and brain abscesses: Clinical
Adult brain tumors
Pediatric brain tumors: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors
Brain tumors: Clinical
Multiple sclerosis
Tourette syndrome
Ataxia-telangiectasia
Huntington disease
Opsoclonus myoclonus syndrome (NORD)
Primary ciliary dyskinesia
Brain herniation
Spinal disc herniation
Multiple myeloma

Transcript

Watch video only

Content Reviewers

Let’s say you want to figure out if a certain medication can lower the systolic blood pressure, so we recruit 100 people, give 50 of them the medication and 50 of them the placebo.

The placebo looks and tastes like the medication but is completely harmless and ineffective - like a tiny capsule filled with water.

After six months of taking the medication or the placebo, you measure the blood pressure of each person in the study.

Now, the unit of measurement for blood pressure is millimeters of mercury, but we’ll just keep it simple and call it “units”.

You find that the mean blood pressure in the medication group is 130 units, and the mean blood pressure in the placebo group is 145 units.

At this point, you might use a statistical test, like unpaired or 2-sample t-test, to see if there’s a significant difference between the two groups’ means.

Typically, an unpaired t-test starts with two hypotheses.

The first hypothesis is called the null hypothesis, and it basically says there’s no difference in the means of the two groups.

For example, our null hypothesis would state that there’s no difference in the mean blood pressure for people that take the placebo compared to people that take the medication.

On the other hand, the alternate hypothesis for a t-test can be either one-sided or two-sided, and this has to be determined at the beginning of the study.

The alternate hypothesis for a one-sided t-test would either state that medication lowers mean blood pressure compared to the placebo or that medication raises mean blood pressure compared to the placebo.

The alternate hypothesis for a two-sided t-test would simply state that the mean blood pressure for the medication group is different than the placebo group, but it wouldn’t specify if medication would raise or lower the mean blood pressure.

Typically, researchers choose to use two-sided t-tests, since they usually don’t know how a treatment will affect the people in the study.

One way to see if there’s a difference between mean blood pressures in the placebo group and the medication group is to make a histogram, which is a plot that shows frequency of an event.

Here, the x-axis represents blood pressure and the y-axis represents the number of people with each blood pressure measurement, and the curve would probably look something like this.

This is called the normal distribution curve, and it’s shaped like a bell, with the majority of people’s blood pressure measurements somewhere around the mean of 145, while fewer and fewer people would have more extreme blood pressures, or blood pressures that are further away from the mean, in the “tails” of the curve.

Now, if the null hypothesis was true, and there really isn’t a difference in the mean blood pressure between the medication and placebo groups, then we’d expect the mean blood pressure of the medication group to be exactly the same as the placebo group, so 145.

But there’s always some amount of natural variation between different groups of people, so we might expect the mean to vary at least a little.

For example, if the medication group just so happened to have a few more people with lower blood pressure, their average blood pressure might be a few units lower than 145.

But what if the mean in the medication group is much lower than 145, or much higher than 145? In other words, the mean might be somewhere in one of these tails.

How do we know if the difference in means that we see is due to natural variation between the groups, or if the difference is significant?